AC-1204
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AC-1204, covering 2012-12-04 to 2021-08-02. Get the full timeline:
Most recent: Clinical Trial Update: AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext [Phase 2, Phase 3]